Published in Int J Rheumatol on July 28, 2010
Renal involvement in autoimmune connective tissue diseases. BMC Med (2013) 1.21
Latest advances in connective tissue disorders. Ther Adv Musculoskelet Dis (2013) 0.85
Thrombotic thrombocytopenic purpura associated with mixed connective tissue disease: a case report. Case Rep Med (2011) 0.83
Extra-renal manifestations of complement-mediated thrombotic microangiopathies. Front Pediatr (2014) 0.81
Scleroderma renal crisis and renal involvement in systemic sclerosis. Nat Rev Nephrol (2016) 0.77
Hypertensive emergencies: a new clinical approach. Clin Hypertens (2015) 0.75
Scleroderma renal crisis in a newly diagnosed mixed connective tissue disease resulting in dialysis-dependent chronic kidney disease despite angiotensin-converting enzyme inhibition. CEN Case Rep (2012) 0.75
Scleroderma renal crisis during intravenous cyclophosphamide pulse therapy for complicated interstitial lung disease was successfully treated with angiotensin converting enzyme inhibitor and plasma exchange. Nagoya J Med Sci (2016) 0.75
Autoantibodies in systemic sclerosis. Semin Arthritis Rheum (2005) 3.55
Antibody-mediated renal allograft rejection: diagnosis and pathogenesis. J Am Soc Nephrol (2007) 2.64
Long-term outcomes of scleroderma renal crisis. Ann Intern Med (2000) 2.27
Scleroderma renal crisis: patient characteristics and long-term outcomes. QJM (2007) 2.14
Outcome of renal crisis in systemic sclerosis: relation to availability of angiotensin converting enzyme (ACE) inhibitors. Ann Intern Med (1990) 2.03
Capillary deposition of C4d complement fragment and early renal graft loss. Kidney Int (1993) 1.80
Antineutrophil cytoplasmic autoantibodies in 6 patients with renal failure and systemic sclerosis. J Rheumatol (1994) 1.62
The relationship of hypertension and renal failure in scleroderma (progressive systemic sclerosis) to structural and functional abnormalities of the renal cortical circulation. Medicine (Baltimore) (1974) 1.62
Autoantibodies to fibrillarin in systemic sclerosis (scleroderma). An immunogenetic, serologic, and clinical analysis. Arthritis Rheum (1996) 1.54
Primer: Histopathology of calcineurin-inhibitor toxicity in renal allografts. Nat Clin Pract Nephrol (2006) 1.47
Case-control study of corticosteroids and other drugs that either precipitate or protect from the development of scleroderma renal crisis. Arthritis Rheum (1998) 1.45
Digital ulcers: overt vascular disease in systemic sclerosis. Rheumatology (Oxford) (2009) 1.29
Altered B lymphocyte function induces systemic autoimmunity in systemic sclerosis. Mol Immunol (2004) 1.20
Renal complications and scleroderma renal crisis. Rheumatology (Oxford) (2009) 1.17
Anti-U3 RNP autoantibodies in systemic sclerosis. Arthritis Rheum (2009) 1.16
Mechanisms of Disease: the role of immune cells in the pathogenesis of systemic sclerosis. Nat Clin Pract Rheumatol (2006) 1.15
A prospective, randomized trial of FK 506/prednisone vs FK 506/azathioprine/prednisone in renal transplant patients. Transplant Proc (1995) 1.13
Endothelial transcripts uncover a previously unknown phenotype: C4d-negative antibody-mediated rejection. Curr Opin Organ Transplant (2010) 1.11
Antibodies to RNA polymerase III in systemic sclerosis detected by ELISA. J Rheumatol (2007) 1.08
Renal proliferative arteriopathies and associated glomerular changes: a light and electron microscopic study. Hum Pathol (1976) 1.07
Normotensive renal failure in systemic sclerosis. Arthritis Rheum (1989) 1.06
Quantitative morphometry of lupus nephritis: the significance of collagen, tubular space, and inflammatory infiltrate. Kidney Int (2005) 1.05
Adult haemolytic and uraemic syndrome: causes and prognostic factors in the last decade. Nephrol Dial Transplant (2002) 1.03
Anti-endothelial cell antibodies in systemic sclerosis. Ann Rheum Dis (2010) 1.02
New developments in the pathogenesis of systemic sclerosis. Autoimmunity (2005) 1.01
In vivo analysis of the apoptosis-inducing effect of anti-endothelial cell antibodies in systemic sclerosis by the chorionallantoic membrane assay. Arthritis Rheum (2003) 0.98
Renal vascular histology and morphometry in systemic sclerosis. A case-control autopsy study. Arthritis Rheum (1988) 0.98
Renal biopsy findings predicting outcome in scleroderma renal crisis. Hum Pathol (2008) 0.97
Antineutrophil cytoplasmic antibody-positive crescentic glomerulonephritis in scleroderma--a different kind of renal crisis. J Rheumatol (2006) 0.96
Scleroderma renal crisis: a rare but severe complication of systemic sclerosis. Clin Rev Allergy Immunol (2011) 0.92
Update on pathophysiology of scleroderma with special reference to immunoinflammatory events. Ann Med (2007) 0.89
Immunohistological study endothelin-1 and endothelin-A and B receptors in two patients with scleroderma renal crisis. Clin Rheumatol (1999) 0.89
Analysis of autoantibodies against RNA polymerases using immunoaffinity-purifed RNA polymerase I, II, and III antigen in an enzyme-linked immunosorbent assay. Clin Immunol Immunopathol (1998) 0.87
Pathologic observations concerning the kidney in progressive systemic sclerosis. AMA Arch Pathol (1958) 0.87
The kidney in progressive systemic sclerosis: immunohistochemical and antibody elution studies. Lab Invest (1976) 0.85
Clinical significance of the distribution of C4d deposits in different anatomic compartments of the allograft kidney. Mod Pathol (2008) 0.85
Immunopathology of the renal vascular lesion of progressive systemic sclerosis (scleroderma). Am J Pathol (1978) 0.85
Relationship between underlying renal disease and renal transplantation outcome. Am J Kidney Dis (2001) 0.83
The management of renal scleroderma: experience with dialysis, nephrectomy and transplantation. Am J Med (1978) 0.83
Renal immune deposits in scleroderma. Pathology (1971) 0.82
Predictors and risk factors for recurrent scleroderma renal crisis in the kidney allograft: case report and review of the literature. Am J Transplant (2005) 0.82
Scleroderma renal crisis with minimal skin involvement and no serologic evidence of systemic sclerosis. Am J Kidney Dis (1994) 0.81
Scleroderma renal crisis: new insights and developments. Curr Rheumatol Rep (2004) 0.81
Outcome of end-stage renal disease in patients with rare causes of renal failure. III. Systemic/vascular disorders. Q J Med (1990) 0.81
Scleroderma with crescentic glomerulonephritis: a case report. J Med Case Rep (2008) 0.81
Kidney involvement in a 17-year-old boy with eosinophilic fasciitis. Clin Nephrol (1999) 0.80
Juxtaglomerular hyperplasia and hyperreninemia in progressive systemic sclerosis complicated acute renal failure. Am J Med (1974) 0.80
Late recurrence of scleroderma renal crisis in a renal transplant recipient despite angiotensin II blockade. Am J Kidney Dis (2005) 0.78
Normotensive scleroderma renal crisis: case report and review of the literature. Ren Fail (1998) 0.78
Scleroderma renal crisis following widespread application of topical triamcinolone. J Clin Rheumatol (2004) 0.77
[Case of scleroderma with rapid progressive glomerulonephritis associated with both MPO-ANCA and anti-GBM antibodies]. Nihon Jinzo Gakkai Shi (2008) 0.77
Electron microscopic study of medical diseases of the kidney: update--1988. Mod Pathol (1988) 0.77
Renal lesions in scleroderma. Angiology (1978) 0.77
Kidney crisis in systemic sclerosis. Rocz Akad Med Bialymst (2005) 0.77
Renal involvement in systemic sclerosis. Clin Dermatol (1994) 0.76
Is scleroderma renal crisis with anti-centromere antibody-positive limited cutaneous systemic sclerosis overlooked in patients with hypertension and/or renal dysfunction? Nephrology (Carlton) (2008) 0.76
Favourable outcome of scleroderma renal crisis. J R Soc Med (1996) 0.76
Scleroderma renal crisis in a patient with anticentromere antibody-positive limited cutaneous systemic sclerosis. Mod Rheumatol (2006) 0.76
2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative. Arthritis Rheum (2013) 5.99
Changes in causes of death in systemic sclerosis, 1972-2002. Ann Rheum Dis (2007) 4.88
2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative. Ann Rheum Dis (2013) 3.11
Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma. N Engl J Med (2015) 3.00
Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trial. Ann Rheum Dis (2010) 2.30
Predictors of isolated pulmonary hypertension in patients with systemic sclerosis and limited cutaneous involvement. Arthritis Rheum (2003) 1.94
Mortality in systemic sclerosis: an international meta-analysis of individual patient data. Am J Med (2005) 1.93
Measuring disease activity and functional status in patients with scleroderma and Raynaud's phenomenon. Arthritis Rheum (2002) 1.91
Disease subsets, antinuclear antibody profile, and clinical features in 127 French and 247 US adult patients with systemic sclerosis. J Rheumatol (2006) 1.85
Responsiveness of the SF-36 and the Health Assessment Questionnaire Disability Index in a systemic sclerosis clinical trial. J Rheumatol (2005) 1.66
Childhood onset systemic sclerosis: classification, clinical and serologic features, and survival in comparison with adult onset disease. J Rheumatol (2006) 1.64
Predictors and outcomes of scleroderma renal crisis: the high-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis trial. Arthritis Rheum (2002) 1.62
Recombinant human relaxin in the treatment of systemic sclerosis with diffuse cutaneous involvement: a randomized, double-blind, placebo-controlled trial. Arthritis Rheum (2009) 1.53
Bladder permeability barrier: recovery from selective injury of surface epithelial cells. Am J Physiol Renal Physiol (2002) 1.44
Validation of potential classification criteria for systemic sclerosis. Arthritis Care Res (Hoboken) (2012) 1.41
Analysis of systemic sclerosis in twins reveals low concordance for disease and high concordance for the presence of antinuclear antibodies. Arthritis Rheum (2003) 1.37
Intravenous administration of hepatocyte growth factor gene ameliorates diabetic nephropathy in mice. J Am Soc Nephrol (2004) 1.36
The localized scleroderma skin severity index and physician global assessment of disease activity: a work in progress toward development of localized scleroderma outcome measures. J Rheumatol (2009) 1.35
Development and initial validation of the localized scleroderma skin damage index and physician global assessment of disease damage: a proof-of-concept study. Rheumatology (Oxford) (2009) 1.23
The Pediatric Rheumatology European Society/American College of Rheumatology/European League against Rheumatism provisional classification criteria for juvenile systemic sclerosis. Arthritis Rheum (2007) 1.23
Enzyme-linked immunosorbent assay for detection of anti-RNA polymerase III antibody: analytical accuracy and clinical associations in systemic sclerosis. Arthritis Rheum (2005) 1.18
Skin thickness progression rate: a predictor of mortality and early internal organ involvement in diffuse scleroderma. Ann Rheum Dis (2010) 1.18
Kidney disease other than renal crisis in patients with diffuse scleroderma. J Rheumatol (2005) 1.18
Anti-U3 RNP autoantibodies in systemic sclerosis. Arthritis Rheum (2009) 1.16
Correlation of serum anti-DNA topoisomerase I antibody levels with disease severity and activity in systemic sclerosis. Arthritis Rheum (2003) 1.15
Prevalence of incidental prostate cancer in the general population: a study of healthy organ donors. J Urol (2008) 1.14
A comparison between anti-Th/To- and anticentromere antibody-positive systemic sclerosis patients with limited cutaneous involvement. Arthritis Rheum (2003) 1.14
Pulmonary arterial hypertension and severe pulmonary fibrosis in systemic sclerosis patients with a nucleolar antibody. J Rheumatol (2007) 1.10
Items for developing revised classification criteria in systemic sclerosis: Results of a consensus exercise. Arthritis Care Res (Hoboken) (2012) 1.06
Clinical subsets, skin thickness progression rate, and serum antibody levels in systemic sclerosis patients with anti-topoisomerase I antibody. Arthritis Rheum (2007) 1.05
Survival and predictors of mortality in systemic sclerosis-associated pulmonary arterial hypertension: outcomes from the pulmonary hypertension assessment and recognition of outcomes in scleroderma registry. Arthritis Care Res (Hoboken) (2014) 1.03
The clinical and morphologic spectrum of renal cryoglobulinemia. Medicine (Baltimore) (2002) 1.03
Ultraviolet radiation intensity predicts the relative distribution of dermatomyositis and anti-Mi-2 autoantibodies in women. Arthritis Rheum (2009) 1.03
Lung transplantation in scleroderma compared with idiopathic pulmonary fibrosis and idiopathic pulmonary arterial hypertension. Arthritis Rheum (2006) 1.03
Effector CD8+ T cells in systemic sclerosis patients produce abnormally high levels of interleukin-13 associated with increased skin fibrosis. Arthritis Rheum (2009) 1.03
A clinical and serologic comparison of African American and Caucasian patients with systemic sclerosis. Arthritis Rheum (2012) 1.02
Large cerebellar lesion as original manifestation of transitional cell carcinoma of the bladder. Urology (2003) 1.02
Anti-U11/U12 RNP antibodies in systemic sclerosis: a new serologic marker associated with pulmonary fibrosis. Arthritis Rheum (2009) 0.99
Utility of a dual immunostain cocktail comprising of p53 and CK20 to aid in the diagnosis of non-neoplastic and neoplastic bladder biopsies. Diagn Pathol (2009) 0.99
Interleukin-13-producing CD8+ T cells mediate dermal fibrosis in patients with systemic sclerosis. Arthritis Rheum (2013) 0.98
Renal biopsy findings predicting outcome in scleroderma renal crisis. Hum Pathol (2008) 0.97
Localized expression of tenascin in systemic sclerosis-associated pulmonary fibrosis and its regulation by insulin-like growth factor binding protein 3. Arthritis Rheum (2012) 0.96
Serum autoantibodies and their clinical associations in patients with childhood- and adult-onset linear scleroderma. A single-center study. J Rheumatol (2008) 0.95
Outcome measurements in scleroderma: results from a delphi exercise. J Rheumatol (2007) 0.94
Membranous nephropathy: a rare renal manifestation of IgG4-related systemic disease. Clin Nephrol (2012) 0.93
Treatment of early diffuse systemic sclerosis skin disease. Clin Exp Rheumatol (2013) 0.91
Seasonal influence on the onset of idiopathic inflammatory myopathies in serologically defined groups. Arthritis Rheum (2005) 0.90
Diabetic nephropathy and long-term treatment effects of rosiglitazone and enalapril in obese ZSF1 rats. J Endocrinol (2011) 0.87
Levofloxacin-induced granulomatous interstitial nephritis. Am J Kidney Dis (2003) 0.86
Autoantibodies to RuvBL1 and RuvBL2: a novel systemic sclerosis-related antibody associated with diffuse cutaneous and skeletal muscle involvement. Arthritis Care Res (Hoboken) (2014) 0.86
Age-associated changes in alpha-methyl CoA racemase (AMACR) expression in nonneoplastic prostatic tissues. Am J Surg Pathol (2005) 0.85
High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis trial: lessons learned. Semin Arthritis Rheum (2004) 0.85
Successful Treatment of Dry Mouth and Dry Eye Symptoms in Sjögren's Syndrome Patients With Oral Pilocarpine: A Randomized, Placebo-Controlled, Dose-Adjustment Study. J Clin Rheumatol (2004) 0.85
p16ink4 immunoreactivity is a reliable marker for urothelial carcinoma in situ. Hum Pathol (2008) 0.84
Anti-PM-Scl antibody in patients with systemic sclerosis. Clin Exp Rheumatol (2012) 0.83
Reliability and validity of the delta finger-to-palm (FTP), a new measure of finger range of motion in systemic sclerosis. Clin Exp Rheumatol (2010) 0.82
Quality indicator set for systemic sclerosis. Clin Exp Rheumatol (2011) 0.81
A 61 year diabetic man with methicillin-sensitive Staphylococcus aureus septic arthritis and acute renal failure: a case of IgA-dominant postinfectious glomerulonephritis. Nephrology (Carlton) (2012) 0.81
Muscle cramps associated with localized scleroderma skin lesions: focal dystonia, neuromyotonia, or nerve entrapment? J Rheumatol (2006) 0.81
Connective tissue diseases: Predicting death in SSc: planning and cooperation are needed. Nat Rev Rheumatol (2011) 0.80
Myasthenia gravis and scleroderma: two cases and a review of the literature. Clin Neurol Neurosurg (2007) 0.80
Estradiol promotes the development of a fibrotic phenotype and is increased in the serum of patients with systemic sclerosis. Arthritis Res Ther (2013) 0.79
T cell lines from systemic sclerosis patients and healthy controls recognize multiple epitopes on DNA topoisomerase I. J Autoimmun (2006) 0.78
Molecular recognition patterns of serum anti-DNA topoisomerase I antibody in systemic sclerosis. J Immunol (2004) 0.77
A novel protein highly expressed in testis is overexpressed in systemic sclerosis fibroblasts and targeted by autoantibodies. J Immunol (2003) 0.77
Significance of palpable tendon friction rubs in early diffuse cutaneous systemic sclerosis. Arthritis Care Res (Hoboken) (2013) 0.77
Pathologic quiz case: a 72-year-old man with fatigue and proteinuria. Angiotropic (intravascular) large B-cell lymphoma. Arch Pathol Lab Med (2003) 0.77
Deposition of complement product C4d in anti-glomerular basement membrane glomerulonephritis. Am J Kidney Dis (2008) 0.77
Amylase α-1A (AMY1A): a novel immunohistochemical marker to differentiate chromophobe renal cell carcinoma from benign oncocytoma. Am J Surg Pathol (2013) 0.76
Prevention and reversal of lupus in NZB/NZW mice by costimulatory blockade with adeno-associated virus-mediated gene transfer. Arthritis Rheum (2005) 0.76
Derivation and validation of a prediction rule for two-year mortality in early diffuse cutaneous systemic sclerosis. Arthritis Rheumatol (2014) 0.76
Sublingual Abnormalities in Systemic Sclerosis. J Clin Rheumatol (2016) 0.76
Commentary on myofascial release therapy in systemic lupus erythematosus and scleroderma. J Bodyw Mov Ther (2011) 0.75
Scleroderma renal crisis: a high index of suspicion speeds diagnosis and life-saving treatment. South Med J (2006) 0.75
Mycobacterium kansasii infection diagnosed by pleural fluid cytology: a case report. Acta Cytol (2007) 0.75
Epididymal angiosarcoma. Urology (2007) 0.75
Cardiac murmur prompting diagnosis of metastatic nonseminomatous germ cell testicular neoplasia in an 18-year-old patient. ScientificWorldJournal (2005) 0.75
Renal cell carcinoma containing fat without associated calcifications: two case reports and review of literature. Urology (2008) 0.75
Hormone therapy in systemic lupus erythematosus. Curr Rheumatol Rep (2005) 0.75
Dr Leroy's contribution to the understanding of systemic sclerosis. Clin Exp Rheumatol (2004) 0.75